Senior insider sale
SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$797.6K
52.80K shares
What this filing means
PODLESAK DENNIS plans to sell 52.80K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $797.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2025ACC: 0001950047-25-005995
Director
Since Jun 2019
52.80K
Shares to sell
$797.6K
Approx. market value
14.40K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/18/2025
14.40KTotal acquired14.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/18/2025 | Exercise of Stock Options Cash | 14.40K | — |
| Total | 14.40K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
19.20K
Market value
$298.4K
8/15/2025
—Completed
Units to sell
19.20K
Market value
$272.5K
8/14/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
14.40K
Market value
$226.7K
8/18/2025
Total
Units
52.80K
Value
$797.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/15/2025 | 19.20K | $298.4K | — | Completed |
8/14/2025 | 19.20K | $272.5K | — | Completed |
| Planned — Approximate Date | ||||
8/18/2025 | 14.40K | $226.7K | NASDAQ | Planned |
| Total | 52.80K | $797.6K | ||